Skip to content

Cardiovascular Disease Risk Factors Prevalence Among Bayer's Employees in São Paulo, Brazil

Descriptive Observational Study of Cardiovascular Health Risk Factors in Workers of Bayer S.A. Company in São Paulo

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02055651
Enrollment
361
Registered
2014-02-05
Start date
2013-08-31
Completion date
2016-10-31
Last updated
2016-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occupational Health

Keywords

Worksite, Cardiovascular, Epidemiology, Risk factors

Brief summary

Introduction: As employees spent most part of their time at the worksite, it provides a venue to address multiple individual risk factors and promote health. The America Heart Association (AHA) defined cardiovascular health using as metrics smoking status, body mass index, physical activity, diet, total cholesterol, blood pressure and fasting blood glucose. Objective: Evaluate Bayer employees' cardiovascular health according to the AHA definition and the acceptance to engage in lifestyle change programs. Methods: By the time of the annual occupational safety periodic medical examination, employees will receive an email with information about the cardiovascular health screening, exams requisition (fasting blood glucose and total cholesterol) and a copy of the written informed consent. If the employee accepts to participate, after providing a written informed consent, he will be evaluated according to the AHA cardiovascular health metrics. Data will be collected at the occupational safety electronic health record. After medical evaluation, employees will receive a printed feedback with their cardiovascular health score and will be referred to indicated lifestyle change programs (healthy weight, smoking cessation, diabetes control, high blood pressure control, dyslipidemia control). After 12 months we will evaluate the percentage of employees who accept to participate; prevalence of the cardiovascular risk factors and distribution according to the AHA classification in ideal, intermediate and poor; adherence to lifestyle change programs.

Interventions

BEHAVIORALExamination and survey

Routine medical examination as required by law and follow-up for lifestyle change program

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Employees with 20 years of age or more that daily work at Bayer's site in São Paulo * Provide written informed consent

Exclusion criteria

* Employees that will no longer work for Bayer in 30 days * Employees that are retired from work during the study period

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular health metrics on a three-point scale (poor, intermediate, ideal)1 dayMetrics are defined by the American Heart Association (AHA) \[Lloyd-Jones and cols, 2010\]

Secondary

MeasureTime frame
Number of participants who are suggested to participate in a lifestyle change program and show up for at least one sessionUp to 4 weeks after cardiovascular examination

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026